Hussman Strategic Advisors Inc. Invests $1.18 Million in Alignment Healthcare, Inc. $ALHC

Hussman Strategic Advisors Inc. acquired a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the 2nd quarter, Holdings Channel reports. The fund acquired 84,000 shares of the company’s stock, valued at approximately $1,176,000.

A number of other institutional investors also recently bought and sold shares of the stock. MCF Advisors LLC increased its stake in Alignment Healthcare by 87.6% during the 1st quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after purchasing an additional 1,011 shares in the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Alignment Healthcare in the 1st quarter valued at $42,000. Signaturefd LLC increased its position in shares of Alignment Healthcare by 142.6% in the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after acquiring an additional 2,215 shares during the period. Amalgamated Bank raised its stake in Alignment Healthcare by 21.6% in the 1st quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock worth $65,000 after acquiring an additional 616 shares during the last quarter. Finally, Greenleaf Trust acquired a new stake in Alignment Healthcare during the 2nd quarter worth about $160,000. 86.19% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, insider Christopher J. Joyce sold 30,939 shares of the company’s stock in a transaction dated Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $507,708.99. Following the completion of the transaction, the insider owned 343,592 shares of the company’s stock, valued at approximately $5,638,344.72. This represents a 8.26% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, President Dawn Christine Maroney sold 215,662 shares of the firm’s stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total value of $3,539,013.42. Following the completion of the sale, the president directly owned 1,797,237 shares in the company, valued at approximately $29,492,659.17. The trade was a 10.71% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 7,427,716 shares of company stock valued at $119,650,069. Insiders own 6.60% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have recently weighed in on ALHC shares. The Goldman Sachs Group reissued a “buy” rating and issued a $22.00 price objective on shares of Alignment Healthcare in a report on Monday. Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. Barclays lifted their price objective on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an “equal weight” rating in a research note on Friday. KeyCorp upgraded shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price objective on the stock in a research note on Monday, August 25th. Finally, UBS Group boosted their target price on shares of Alignment Healthcare from $17.00 to $18.00 and gave the company a “neutral” rating in a research report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $19.75.

Alignment Healthcare Trading Up 1.5%

Alignment Healthcare stock opened at $17.09 on Wednesday. The firm has a market cap of $3.42 billion, a PE ratio of -142.42 and a beta of 1.17. Alignment Healthcare, Inc. has a 12 month low of $10.18 and a 12 month high of $21.06. The stock’s 50 day simple moving average is $16.94 and its two-hundred day simple moving average is $15.46. The company has a current ratio of 1.61, a quick ratio of 1.61 and a debt-to-equity ratio of 1.99.

Alignment Healthcare (NASDAQ:ALHC) last posted its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.03. Alignment Healthcare had a negative net margin of 0.57% and a negative return on equity of 16.23%. The firm had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. During the same period in the previous year, the firm earned ($0.14) EPS. The business’s quarterly revenue was up 43.5% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. Analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.